Article 29 Oct 2025 FDA Presses Forward On Patient-Focused Drug Development, Releases Final Guidance Focused On Fit-For-Purpose Clinical Outcome Assessments United States Healthcare
Article 24 Oct 2025 FDA Names The First Nine National Priority Voucher Recipients United States Healthcare
Article 13 Oct 2025 FDA Continues Focus On AI Fronts, Seeks Public Comment On Measuring And Evaluating AI-enabled Medical Device Performance In The Real-World United States Healthcare
Article 06 Oct 2025 The Trump Administration Continues To Make Drug Pricing Moves, Announces First MFN Agreement United States Healthcare
Article 01 Oct 2025 FDA Presses Forward On PDUFA VII CGT Commitments With Release Of Draft Guidance On Clinical Trial Design, Methods For Capturing Postapproval Data United States Healthcare
Article 29 Sep 2025 FDA's Latest On Emergency Diagnostics And A No-Frills Rescission Of The LDT Rule United States Healthcare
Article 16 Sep 2025 From Foods To Pharmaceuticals, MAHA Strategy Offers Broad Menu Of FDA Actions United States Healthcare
Article 10 Sep 2025 FDA Continues Focus On Rare Disease Drug Development, Announces Evidence Principles United States Healthcare
Article 04 Sep 2025 Five Health Care Issues To Watch As Congress Returns From August Recess United States Healthcare
Article 28 Aug 2025 OMUFA Reauthorization On Deck As Congress Returns From Recess United States Healthcare
Article 08 Jul 2025 Republicans Pass The One Big Beautiful Bill Act Ahead Of The July 4 Deadline United States Strategy
Article 25 Jun 2025 FDA Announces Commissioner's National Priority Voucher Program To Accelerate Drug Application Review Process And Support National Priorities United States Healthcare
Article 09 Jun 2025 No Appeal Of LDT Decision Means Ball Is Back In FDA's Court For Policy Clarification United States Healthcare
Article 27 May 2025 MAHA Commission Report On Children's Health Takes Aim At Ultra-Processed Foods And Medication Practices, Among Other Targets United States Healthcare